Mirati Therapeutics (MRTX) PT Raised to $134 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Edward White raised the price target on Mirati Therapeutics (NASDAQ: MRTX) to $134.00 (from $117.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
